Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma
R. Kane, H. Harvey, T. Andrews, A. Bernath, S. Curry, R. Dixon, R. Gottlieb, M. Kukrika, A. Lipton, R. Mortel, J. Ricci, D. White
Dive into the research topics of 'Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma'. Together they form a unique fingerprint.